Provision of full diagnostic histopathology service

Location

Musgrove Park Hospital

Description

Provision of full diagnostic histopathology services.

Total Quantity or Scope

Provision of full diagnostic histopathology services including but not limited to Her2 Testing, Placenta (wet to report) PD-L1 and Ki67. The Authority is intending to award a contract to an existing provider following direct award process C.The lifetime value of this contract is expected to be £156,000.00The contract dates are 01.08.26 - 31.07.27

Award Detail

Award Criteria

CPV Codes

• 85111800 - Pathology services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 13 July 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by midnight on 13 July 2026 via email to servicesteam.procurement@somersetft.nhs.uk. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.The decision makers were: Deputy Service Group Director, CSCSNo conflicts of interest were declared among decision makers.The key criteria were weighted as follows:40% quality and Innovation20% Value15% Integration, Collaboration and Service Sustainability15% Improving access, reducing health inequalities and facilitating choice10% Social valueThe highest weighting has been applied to quality and innovation as the key objective is maintaining a high-quality service. The other elements of a quality led service have been weighted at 40%. Value in terms of cost has been weighted 20% because maintaining the quality of the service is the main objective of this award.The rationale for choosing the provider with reference to the key criteria:The existing supplier is an established services provider with a proven track record, and they are highly likely to be able to satisfy the new contract to a sufficient standard.